Potassium Citrate
6100-05-6O.O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[K+].[K+].[K+]PJAHUDTUZRZBKM-UHFFFAOYSA-KPotassium citrate monohydrate is a hydrate that is the monohydrate form of potassium citrate. It has a role as a diuretic. It contains a potassium citrate (anhydrous).
6100-05-6、866-84-2FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
This chemical does not meet GHS hazard criteria for 100% (181 of 181) of all reports.
Not Classified
Aggregated GHS information provided per 181 reports by companies from 2 notifications to the ECHA C&L Inventory.
Not Classified
Chemical: 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, tripotassium salt, monohydrate
Tripotassium citrate monohydrate: Does not have an individual approval but may be used under an appropriate group standard
Not Classified
Not Classified
2.1 [mg/m3]
23 [mg/m3]
140 [mg/m3]
2.2 [mg/m3]
24 [mg/m3]
150 [mg/m3]
A - Alimentary tract and metabolism
QA - Alimentary tract and metabolism
Potassium citrate induces changes in the urine which renders urine less susceptible to the formation of crystals and stones from salts e.g. calcium oxalate, calcium phosphate and uric acid. Increased citrate levels in the urine will make complexation with calcium which decrease the calcium ion activity and decrease the chance for the formation of calcium phosphate crystals. Citrate also inhibits the spontaneous nucleation of calcium oxalate and calcium phosphate.
After oral administration of potassium citrate, its metabolism yields alkaline load. Potassium Citrate therapy appears to increase urinary citrate mainly by modifying the renal handling of citrate, rather than by increasing the filtered load of citrate. In addition to raising urinary pH and citrate, Potassium Citrate increases urinary potassium by approximately the amount contained in the medication. In some patients, Potassium Citrate causes a transient reduction in urinary calcium.
KALI CITRICUM
Acidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Decreased Coagulation Factor Activity [PE]
POTASSIUM CITRATE
Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Decreased Coagulation Factor Activity [PE]; Acidifying Activity [MoA]; Anti-coagulant [EPC]
Agents that promote the excretion of urine through their effects on kidney function.
Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here.
DTXSID8042501CHEMBL3989822CHEBI:64746White/clear crystalline powder
CIR ingredient: Potassium Citrate
Used in food (sequestrant, emulsifier, and stabilizer) and in medicine as an alkalinizing agent and antiurolithic; [Merck Index] Used as a flavoring agent, nutritional supplement, pH control agent, and sequestrant for foods; [FDA]
Information on 2 consumer products that contain Potassium Citrate in the following categories is provided:
Information on 29 consumer products that contain Potassium Citrate in the following categories is provided:
EPA Safer Chemical Functional Use Classes -> Chelating Agents;Processing Aids and Additives
Safer Chemical Classes -> Green circle - The chemical has been verified to be of low concern
Food Additives -> ACIDITY_REGULATOR; SEQUESTRANT; STABILIZER -> JECFA Functional Classes
용도Tripotassium Citrate Monohydrate is used in manufacturing method of printed circuit board for autonomous vehicle to perform recognition, judgment, determination and execution.Citric acid is a weak organic acid that is known as a commodity chemical, as more than a million tonnes are produced every year by mycological fermentation on an industrial scale using crude sugar solutions, such as molasses and strains of Aspergillus niger. Citric acid is widely distributed in plants and in animal tissues and fluids and exist in greater than grace amounts in variety of fruits and vegetables, most notably in citrus fruits such as lemon and limes. Citric acid is mainly used as an acidifier, flavoring agent and chelating agent. Citric acid is also a metabolite of Dimethyl Fumarate (D464965), a compound
일반 설명Potassium citrate tribasic monohydrate (KCTM) is a potassium salt that has been reported to be efficient in forming aqueous two-phase system (ATPS) with UCON 50-HB-5100, a random copolymer. This product is a high quality pharmacopoeia product that meets the testing specifications of USP (United States Pharmacopoeia). It can be employed in research and pilot studies.
생산 방법Potassium citrate is prepared by adding either potassium bicarbonate or potassium carbonate to a solution of citric acid until effervescence ceases. The resulting solution is then filtered and evaporated to dryness to obtain potassium citrate.
순도시험(1) 비소 : 이 품목을 비소시험법에 따라 시험할 때, 그 양은 1.3ppm 이하이어야 한다. (2) 납 : 이 품목 5.0g을 취하여 원자흡광광도법 또는 유도결합플라즈마발광광도법에 따라 시험할 때, 그 양은 1.0ppm 이하이어야 한다. (3) 수은 : 이 품목을 수은시험법에 따라 시험할 때, 그 양은 1.0ppm 이하이어야 한다. (4) 알칼리도 : 이 품목의 수용액(1→20)은 리트머스시험지에 반응시킬 때, 알칼리성을 나타낸다.
정량법이 품목을 건조한 다음 250mg을 정밀히 달아 빙초산 40mL를 넣어 약간 가열하여 용해시킨 후 실온으로 냉각하여 0.1N 과염소산용액으로 적정한다(지시약 : 크리스탈바이올렛․빙초산시액 2방울). 따로 같은 방법으로 공시험을 한다.0.1N 과염소산용액 1mL = 10.213mg C6H5K3O7
정의ChEBI: A hydrate that is the monohydrate form of potassium citrate.